It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about ...

New York, New York-- (Newsfile Corp. - March 14, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...

NEW YORK, NY / ACCESS Newswire / March 14, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...

TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a ...

BNY Mellon Small Cap Growth Fund outperformed its benchmark, the Russell 2000 Growth Index during Q4 2024. Click here to read ...

TransMedics Group's organ care system can preserve multiple organs, but livers are responsible for 70% of total sales. OrganOx markets a normothermic machine perfusion device approved to preserve ...

The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. . Shareholders who purchased shares of ...

SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ ...

It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about 62% from the peak it set last August. The company's warm perfusion ...

The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 7.34%% during the fourth quarter of 2024. Click here to read the full commentary.

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group, Inc. publicly traded securities between February 28, 2023 and January 10, 2025, both dates inclusive (the ...

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX ...